Cadavedo, Ian Rose .

HRN: 14-28-34  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/20/2022
CEFUROXIME 750MG (VIAL)
09/20/2022
09/23/2022
IVT
750mg
Q8 X 3 Days
S/P CS

 Indication:  ProphylaxisEmpiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Non-compliant To Guidelines